XORTX Therapeutics Inc.: XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection
CALGARY, AB / ACCESSWIRE / March 8, 2021
/ XORTX Therapeutics Inc.
XORTX or the
Company ) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, with late-stage clinical programs, is pleased to announce the filing of a new provisional patent application entitled Compositions and Methods for Enhancing Anti-Viral Therapies . This provisional patent was filed with the US Patent Office on Friday, March 5, 2021.
In addition, studies of Coronavirus infections show that SARS and MERS and specifically COVID-19 can be frequently accompanied by pneumonia, acute kidney injury, proteinuria and hematuria
Towards an HIV Cure
MISSION: To drive concerted efforts to accelerate global scientific research and engagement towards a cure for HIV.
The toolbox of interventions for fighting the global HIV pandemic has grown exponentially since the discovery of the virus, but a cure has remained beyond our grasp. In recent years, however, research to develop a cure for HIV or long-term remission has made promising progress, galvanizing researchers, advocates and community members alike. To that end, the mission of the IAS Towards an HIV Cure initiative is to drive concerted efforts to accelerate global scientific research and engagement towards a cure for HIV.
Farming Newsletter
Enter email address
Sign Up
“It’s a small business for now, but I’ve built up a really nice set of customers in Westmeath, Dublin and Longford. They are happy with the product.
“Before I started I had never held a chainsaw so it was very entertaining because I was with a group of guys and I really didn’t know what I was doing. I didn’t realise you needed to put chain oil in and I put the chain on backwards once too,” she laughed.
While there aren’t many female chainsaw operators in traditional forestry, Olive has been “pleasantly surprised” at how people have responded, particularly her colleagues in the Westmeath Farm Forestry Group.